| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/30/2009 | CN101548008A Preparation of inactivated artificial antigen presenting cells and their use in cell therapies |
| 09/30/2009 | CN101544984A Flavanone 3-hydroxylase protein coded sequence of scutellaria viscidula bge |
| 09/30/2009 | CN101544977A Extreme early gene promoter of white spot syndrome virus, cloning method thereof and application thereof |
| 09/30/2009 | CN101544976A Bidirectional promoter bi-visual fluorescent protein report gene plant expression vector |
| 09/30/2009 | CN101544975A Report gene cell model for screening medicament and construction method thereof |
| 09/30/2009 | CN101544962A EV virus wide spectrum monoclonal antibody and its uses |
| 09/30/2009 | CN101544946A Apparatus and method for cleaning cell, tissue or biological material |
| 09/30/2009 | CN101544691A Gene TUD1 for controlling rice height and grain shape and application thereof |
| 09/30/2009 | CN101544689A Leptospira vaccine candidate outer membrane protein |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543184A Method for culturing open type tissue of konjak |
| 09/30/2009 | CN100545261C Novel phospholipases and uses thereof |
| 09/30/2009 | CN100545260C Separating and culturing process of human amnion mesenchyme stem cell and its medical composition |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/29/2009 | US7595438 Plants and seeds of hybrid corn variety CH808812 |
| 09/29/2009 | US7595437 Plants and seeds of hybrid corn variety CH790925 |
| 09/29/2009 | US7595436 Inbred maize variety PHE3D |
| 09/29/2009 | US7595432 use molecular genetic markers to identify, select and/or construct disease-tolerant plants; generating a disease resistance soybean plant protecting from fungi infection |
| 09/29/2009 | US7595431 Mouse models of human prostate cancer |
| 09/29/2009 | US7595384 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering; improve plant breeds |
| 09/29/2009 | US7595377 No surface carbohydrate moieties which are susceptible to glycosidase digestion; for implantation into humans; subjecting collagen-containing material to a cellular disruption treatment; digesting with a glycosidase to remove first surface carbohydrate moieties |
| 09/29/2009 | US7595375 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 09/29/2009 | US7595194 Isolation of mammalian CNS glial-restricted precursor cells |
| 09/29/2009 | US7595193 Propagation and/or derivation of embryonic stem cells |
| 09/29/2009 | US7595192 Obtained by inducing necrosis by temperature in tumor cells and lysing the necrotic tumor cells; vaccines against cancers, tumorous diseases, infections and/or autoimmune diseases |
| 09/29/2009 | US7595184 Nitrile hydratase variant |
| 09/29/2009 | US7595175 Polyketides and their synthesis |
| 09/29/2009 | US7595166 Methods of screening modulators of T2R taste receptors |
| 09/29/2009 | US7595165 Contacting CD16 receptor-expressing cells in a reaction medium in the presence of the antibody with the antigen of the antibody, and measuring the quantity of at least one cytokine produced by the CD16 receptor-expressing cell; for increased antibody-dependent cellular cytotoxicity (ADCC) activity |
| 09/29/2009 | US7595149 Methods for cancer detection |
| 09/29/2009 | US7595148 Methods and compositions for modulating T lymphocytes |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | US7595043 Method for processing and using adipose-derived stem cells |
| 09/29/2009 | US7595042 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |
| 09/29/2009 | CA2425852C Cytomegalovirus intron a fragments |
| 09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
| 09/29/2009 | CA2319701C Method of promoting erythropoiesis |
| 09/29/2009 | CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/27/2009 | CA2660626A1 Tissue extraction and collection device |
| 09/24/2009 | WO2009117721A1 Hybrid biomedical device fabricated from biomaterials and coated with a cell culture derived ecm coating |
| 09/24/2009 | WO2009117675A1 Low aspect ratio diffusing fiber tip |
| 09/24/2009 | WO2009117597A1 Modulation of the immune response |
| 09/24/2009 | WO2009117553A2 Enhancing vessel lesion homing and repair potential of stem cells |
| 09/24/2009 | WO2009117439A2 Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
| 09/24/2009 | WO2009117098A2 Methods for stem cell production and therapy |
| 09/24/2009 | WO2009117011A1 Tumor cell vaccines |
| 09/24/2009 | WO2009116951A2 Microcarriers for stem cell culture |
| 09/24/2009 | WO2009116893A1 Method for producing endothelial cells (variants) |
| 09/24/2009 | WO2009116840A2 Chemical reagents regulating stem cell fate |
| 09/24/2009 | WO2009116491A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof |
| 09/24/2009 | WO2009116087A1 Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
| 09/24/2009 | WO2009115522A1 Kit for collecting blood, preferably peripheral blood, for the production of stem cells |
| 09/24/2009 | WO2009115495A1 Method for increasing recloning efficiency |
| 09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | WO2009115295A1 Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination |
| 09/24/2009 | WO2009114949A1 Methods for deprogramming somatic cells and uses thereof |
| 09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
| 09/24/2009 | WO2009055711A3 Anti-rsv g protein antibodies |
| 09/24/2009 | WO2008096196A8 A medium for cell culture |
| 09/24/2009 | WO2008081456A3 Composition and method for enhancing cell growth and cell fusion |
| 09/24/2009 | WO2007136988A8 Compounds and methods for modulating expression of gccr |
| 09/24/2009 | WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/24/2009 | US20090241230 Expression cassettes for seed-preferential expression in plants |
| 09/24/2009 | US20090241227 Expression cassettes for seed-preferential expression in plants |
| 09/24/2009 | US20090241226 Gene Encoding Lignan Methylation Enzyme |
| 09/24/2009 | US20090241225 Alteration of embryo/endosperm size during seed development |
| 09/24/2009 | US20090241224 Transgenic plant that expresses Rubisco Activase derived polypeptides, or nucleic acids that express the polypeptides, that are more thermostable than naturally occurring Rubisco Activase; expression or activity of endogenous Rubisco Activase of the plant may be eliminated; Arabidopsis |
| 09/24/2009 | US20090241219 Gdc-2 genes conferring herbicide resistance |
| 09/24/2009 | US20090241215 Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants |
| 09/24/2009 | US20090241214 using genetic markers in breeding methods for producing plants with increased resistance to aphid damage and tolerance, while retaining and acquiring desired agronomic traits |
| 09/24/2009 | US20090241213 Cotton variety 565452g |
| 09/24/2009 | US20090241212 Cotton variety 468300g |
| 09/24/2009 | US20090241211 Cotton variety 303308g |
| 09/24/2009 | US20090241210 Cotton variety 779020g |
| 09/24/2009 | US20090241208 Improving cold resistance of transgenic plants with nucleic acids encoding cold tolerance-modulating polypeptides |
| 09/24/2009 | US20090241207 Expression of heterologous genes according to a targeted expression profile |
| 09/24/2009 | US20090241206 Methods for cloning ferrets and transgenic ferret models for diseases |
| 09/24/2009 | US20090241205 Collapsin Response Mediator Protein, CRMP; lacosamide a new analgesic and antiepileptic agent, interacts with CRMP; drug screening, pharmacogenetics |
| 09/24/2009 | US20090241203 Transgenic animal models of disease |
| 09/24/2009 | US20090241202 Domain-grafted antibodies |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/24/2009 | US20090239932 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 09/24/2009 | US20090239884 Methods of Treating Inflammation |
| 09/24/2009 | US20090239868 Inhibitor of pai-1 production |
| 09/24/2009 | US20090239859 Protein kinase modulators |
| 09/24/2009 | US20090239816 Multitargeting Interfering RNAs And Methods Of Their Use And Design |
| 09/24/2009 | US20090239814 Carbohydrate Conjugates as Delivery Agents for Oligonucleotides |
| 09/24/2009 | US20090239806 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 09/24/2009 | US20090239802 Hsp70 PEPTIDE STIMULATING NATURAL KILLER (NK) CELL ACTIVITY AND USES THEREOF |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239799 Pharmaceutical Compositions Comprising Ccl2 and Use of Same For The Treatment of Inflammation |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239305 Gene recombination exchange system for stable gene modification in human ES cells |